Biopolym. Cell. 2008; 24(2):176-179.
Short Communications
Dephosphorylation of tuberous sclerosis complex 2 by serine/threonine protein phosphatase 5
1, 2Malanchuk O. M., 1Palchevskyy S. S., 1Filonenko V. V.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680
  2. Taras Shevchenko National University of Kyiv
    64, Volodymyrska Str., Kyiv, Ukraine, 01601


We report here for the first time specific interaction between tuberous sclerosis complex 2 (TSC2) and protein phosphatase 5 (PP5) in mammalian cells. We found that the interaction is stronger in exponentially growing and serum stimulated cells when compared to serum starved cells. In addition, we provide the evidence that PP5 dephosphorylates specifically TSC2 at sites, associated with its activation via AMP kinase (AMPK) pathway. Taken together, these results suggest that PP5 exerts negative regulation on TSC1/2 function through dephosphorylation of AMPK-mediated sites.
Keywords: protein phosphatase 5, tuberous sclerosis complex 2, dephosphorylation


[1] Barron RP, Kainulainen VT, Forrest CR, Krafchik B, Mock D, S?ndor GK. Tuberous sclerosis: clinicopathologic features and review of the literature. J Craniomaxillofac Surg. 2002;30(6):361-6.
[2] Manning BD, Cantley LC. Rheb fills a GAP between TSC and TOR. Trends Biochem Sci. 2003;28(11):573-6.
[3] Gao X, Zhang Y, Arrazola P, Hino O, Kobayashi T, Yeung RS, Ru B, Pan D. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol. 2002;4(9):699-704.
[4] Saucedo LJ, Gao X, Chiarelli DA, Li L, Pan D, Edgar BA. Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat Cell Biol. 2003;5(6):566-71.
[5] Stocker H, Radimerski T, Schindelholz B, Wittwer F, Belawat P, Daram P, Breuer S, Thomas G, Hafen E. Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat Cell Biol. 2003;5(6):559-65.
[6] Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18(16):1926-45.
[7] Fingar DC, Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene. 2004;23(18):3151-71.
[8] Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003;115(5):577-90.
[9] Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell. 2005;121(2):179-93.
[10] Roux PP, Ballif BA, Anjum R, Gygi SP, Blenis J. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc Natl Acad Sci U S A. 2004;101(37):13489-94.
[11] Hengstschlager M, Rodman DM, Miloloza A, Hengstschlager-Ottnad E, Rosner M, Kubista M. Tuberous sclerosis gene products in proliferation control. Mutat Res. 2001;488(3):233-9.
[12] Shamji AF, Nghiem P, Schreiber SL. Integration of growth factor and nutrient signaling: implications for cancer biology. Mol Cell. 2003;12(2):271-80.
[13] Malanchuk, O.M., Pozur, V., Panasyuk, G.G., Nemazanyy, I.O., Filonenko, V.V., Gout, I.T., Palchevskyy, S.S. Identification of novel binding partners for tuberous sclerosis complex 2 (TSC2) by yeast two-hybrid approach (2005) Experimental Oncology, 27 (3), pp. 186-190.
[14] Malanchuk O.M., Palchevskyy S.S., Pozur V.K., Gout I.T., Filonenko V.V. Interaction of serine/threonine protein phosphatase 5 with the protein products of tumour suppressor gene Tsc2. Biopolym. Cell. 2007; 23 (4):318-323.
[15] Malanchuk O, Palchevskyy S, Ovcharenko G, Gwalter J, Pozur V, Gout I, Filonenko V. Generation and characterization of monoclonal antibodies against tuberous sclerosis complex 2. Hybridoma (Larchmt). 2007;26(4):259-66.
[16] Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005;1(1):15-25.